Brief: Michael Torok Reports 8% Stake In Catalyst Biosciences Inc - SEC Filing
June 21 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* MICHAEL TOROK REPORTS AN 8% STAKE IN CATALYST BIOSCIENCES INC AS OF JUNE
13,
2022 - SEC FILING
* MICHAEL TOROK - BELIEVE CATALYST BIOSCIENCES SHARES, WHEN PURCHASED, WERE
UNDERVALUED & REPRESENTED AN ATTRACTIVE INVESTMENT OPPORTUNITY - SEC FILING
Source text for Eikon: ID:
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes